wins fda approval - Robuta Search

https://www.medtechdive.com/news/device-to-preserve-donor-lungs-wins-fda-approval/553721/ Device to preserve donor lungs wins FDA approval | MedTech Dive The system could expand availability of donor lungs by preserving the organ for up to five hours, giving the transplant team time to reassess marginal lungs... wins fda approval device preserve donor lungs https://www.biopharmadive.com/news/ferring-fda-approval-bladder-cancer-gene-therapy/639078/ Ferring wins FDA approval for bladder cancer gene therapy | BioPharma Dive The OK caps a long development journey for the treatment, which was previously turned back by the agency. Ferring doesn’t expect it to be available until the... wins fda approval bladder cancer gene therapy ferring biopharma https://www.medtechdive.com/news/abbott-heart-device-for-premature-babies-wins-fda-approval/546051/ Abbott heart device for premature babies wins FDA approval | MedTech Dive The device for sealing a hole in the heart of premature infants is smaller than a pea and can treat newborns weighing as little as 2 pounds. wins fda approval premature babies abbott heart device https://www.biopharmadive.com/news/gsks-5-in-1-meningococcal-shot-wins-fda-approval/740144/ GSK’s 5-in-1 meningococcal shot wins FDA approval | BioPharma Dive Feb 18, 2025 - Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through 25 years old. wins fda approval meningococcal shot biopharma dive https://www.biopharmadive.com/news/pfizer-fda-approval-meningococcal-vaccine-penbraya/697441/ Pfizer wins FDA approval of new meningococcal vaccine | BioPharma Dive The clearance of the pentavalent shot Penbraya adds to Pfizer’s infectious disease portfolio as it adjusts to slumping COVID-19 vaccine sales. wins fda approval meningococcal vaccine pfizer new biopharma https://www.biopharmadive.com/news/ascendis-fda-approval-yuviwel-achondroplasia-biomarin-voxzogo/813502/ Ascendis wins FDA approval of dwarfism drug | BioPharma Dive Yuviwel, a once-weekly injection, will now compete for market share with BioMarin’s lucrative daily shot Voxzogo. wins fda approval ascendis drug biopharma dive https://www.medtechdive.com/news/cardiva-wins-fda-approval-for-its-vascular-closure-system/544733/ Cardiva wins FDA approval for its vascular closure system | MedTech Dive The Santa Clara, California-based company succeeded in its PMA application and can now market the Vascade MVP device for use in electrophysiology procedures. wins fda approval vascular closure system medtech https://www.medtechdive.com/news/saturated-oxygen-treatment-for-heart-attack-wins-fda-approval/552095/ Saturated oxygen treatment for heart attack wins FDA approval | MedTech Dive The catheter-based device from Irvine, California-based TherOx aims to reduce muscle damage by delivering hyperbaric levels of oxygen to heart tissue. wins fda approval heart attack saturated oxygen treatment https://www.biopharmadive.com/news/moderna-rsv-vaccine-fda-approval/715544/ Moderna wins FDA approval for RSV vaccine | BioPharma Dive The OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer. wins fda approval rsv vaccine moderna biopharma dive https://www.medtechdive.com/news/guardant-fda-approval-Shield-colon-cancer-blood-test/722665/ Guardant wins FDA approval for colon cancer blood test | MedTech Dive Colorectal cancer screening rates could increase if the Shield test appeals to people who have avoided colonoscopies or stool-based tests, the company said. wins fda approval cancer blood test guardant colon medtech https://www.medtechdive.com/news/Johnson-JJ-FDA-approval-Varipulse-PFA/732277/ J&J wins FDA approval for Varipulse PFA system | MedTech Dive wins fda approval pfa system medtech dive https://www.biopharmadive.com/news/pfizer-rsv-vaccine-fda-approval-abrysvo/651630/ Pfizer’s RSV vaccine wins FDA approval in older adults | BioPharma Dive The shot’s clearance comes several weeks after the regulator made GSK’s Arexvy the first vaccine for RSV in the U.S. wins fda approval rsv vaccine older adults biopharma dive